Announcements Trials
Browse Landscape

Phase

Phase NA 41Phase 2 6Phase EARLY_PHASE1 2Phase 4 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 13Neoplasms 12Glioma 12Prostatic Neoplasms 11Glioblastoma 11Colorectal Neoplasms 10Brain Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Melanoma 8Lymphoma, B-Cell 8Lymphoma 8Recurrence 7Multiple Myeloma 7Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Lung Neoplasms 3Carcinoma, Transitional Cell 3

Interventions

Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Anxiety Disorders × 90 days × Clear all
NCT05086250 2026-05-08

Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
Gastrointestinal

Anxiety Disorders, Pancreatic Neoplasms

NCT00737399 2026-04-27

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

Soul Medicine Institute

Phase EARLY_PHASE1 Active not recruiting
14 enrolled
Gastrointestinal

Anxiety Disorders, Depression, Sleep Initiation and Maintenance Disorders, Neoplasms, Pain, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡